1. Department
of Medicinal Chemistry, Cardiovascular and Metabolic Diseases, Innovative
Medicines and Early Development Biotech Unit, AstraZeneca, Pepparedsleden
1, SE-431 83, Mölndal, Sweden
2. Department
of Medicinal Chemistry, Division of Organic Pharmaceutical Chemistry,
BMC, Uppsala University, Box 574, SE-751 23, Uppsala, Sweden
3. Department
of Medicinal Chemistry, Science for Life Laboratory, BMC, Uppsala University, Box
574, SE-751 23 Uppsala, Sweden